Wtree Us M-Cp Fund

Jazz Pharmaceuticals Director O'Keefe Sold 603 Shares of Company Stock

APA Corporation Sees Significant Increase in Call Option Volume

William Blair Rates Ovintiv Inc. as 'Outperform' With a Price Target

Jazz Pharmaceuticals to Present Ziihera® Phase 3 Trial Results at ASCO GI 2026

BofA Global Research Raises Bunge's Price Target to $112

Bruce C Cozadd sold 77,500 shares of Jazz Pharmaceuticals

Ovintiv Inc. Secures $1.2B Loan to Fund Acquisition of NuVista Energy Ltd.

APA Corporation Receives 'Hold' Ratings from 24 Analysts, Target Price at $25.90

Capital One Financial Downgrades Ovintiv's Q4 2025 EPS Forecast

William Blair Rates Ovintiv as Outperform

Bunge Global Exec VP Reports Sale of Common Stock

Rupert Murdoch Sells Fox Corporation Stock

Jazz Pharmaceuticals Director Heather Ann McSharry Sells Shares

Universal Beteiligungs Increases Stake in APA Corporation

UBS Analyst Maintains Hold Rating on Jazz Pharma

DNB Asset Management Reduced Holdings in Tenet Healthcare

Roivant Sciences Ltd. Director Sells Common Stock

QVT Financial LP sells common stock of Roivant Sciences Ltd.

Jazz Pharmaceuticals Director Sells Ordinary Shares

Jazz Pharmaceuticals VP Exercises Options and Sells Shares

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Tradr 2X Long ASTS Daily ETF

Able View Global

JAZZ

Director Kenneth W. O'Keefe of Jazz Pharmaceuticals Plc surrendered 603 shares back to the company to cover option exercise costs and/or tax liabilities. The transaction was filed with the SEC on December 4, 2025, at a price of $173.07 per share, totaling $104,361. O'Keefe's ending holdings are 30,256 shares, with 25,811 direct and 4,445 indirect.

Reuters

Jazz Pharma

Dir O'Keefe Surrenders 603 Of Jazz Pharmaceuticals Plc [JAZZ]

AES Corp. shares rose 1.60% to $13.93, outperforming competitors like NextEra Energy, Duke Energy, and Dominion Energy on a mixed trading day. The stock broke a three-day losing streak, closing 10.19% below its 52-week high. Trading volume was slightly below the 50-day average. The S&P 500 rose 0.11%, while the Dow Jones fell 0.07%. Data was compiled by Dow Jones Market Data and FactSet.

Dow Jones

AES Corp. Stock Outperforms Competitors On Strong Trading Day

APTV

Aptiv PLC's stock fell 2.11% to $76.44 on Thursday, underperforming compared to competitors like Cummins Inc. and BorgWarner Inc. The stock broke a two-day winning streak and is 13.92% below its 52-week high. Trading volume was below the 50-day average.

Aptiv

Aptiv PLC Stock Underperforms Thursday When Compared To Competitors

APA Corporation (NASDAQ:APA) experienced a significant increase in call options trading, with 21,526 options acquired, marking an 85% rise from the average daily volume. Analysts have mixed ratings on APA, with a consensus 'Hold' rating and a target price of $25.90. Institutional investors have adjusted their stakes, and APA's stock performance shows a recent increase, trading at $26.56. The company reported strong quarterly earnings, beating estimates, and announced a quarterly dividend of $0.25 per share.

Market Beat

Investors Purchase High Volume of APA Call Options (NASDAQ:APA)

AES Corp. stock fell 1.79% to $13.71 on Wednesday, underperforming compared to competitors like NextEra Energy, which rose 0.44%. This marks AES Corp.'s third consecutive day of losses, closing 11.61% below its 52-week high. Trading volume was 1.5 million below its 50-day average.

AES Corp. Stock Underperforms Wednesday When Compared To Competitors

Energy firms' stocks rose as crude prices increased after Moscow peace talks with U.S. officials failed to reach a breakthrough on a Ukraine peace deal. The S&P 500 energy index rose by 1.1%, with Brent crude futures up 0.79% and U.S. West Texas Intermediate crude up 0.9%. Major oil and gas companies like Exxon, Chevron, APA Corp, and others saw significant gains, with Halliburton and SLB also rising. Refiners Phillips 66 and Valero Energy experienced marginal increases.

Valero Energy Corp New

Chevron

BUZZ-Energy firms rise as Moscow peace talks fail to reach breakthrough

Ovintiv Inc. (NYSE:OVV) ranks among the best energy stocks with huge upside potential. William Blair started tracking Ovintiv Inc. (NYSE:OVV) on November 26 with an Outperform rating and a $50 price target. The firm highlighted the company’s recent acquisition of NuVista as a positive driver, pointing out that it “accretively adds core liquids inventory with […]

Ovintiv

William Blair Highlights Ovintiv’s (OVV) Strong Infrastructure Across Montney and Permian

Renowned astronomers are urging the Chilean government to protect the Atacama Desert's night sky from a proposed renewable energy project by AES Andes. The project threatens the Paranal Observatory with increased light pollution, dust, and atmospheric turbulence. Scientists argue that economic development and scientific progress must coexist without compromising one of Earth's best astronomical sites. AES Corp. claims the project complies with regulations. The controversy highlights the global tension between preserving natural darkness and industrialization.

Yahoo Finance

Renowned astronomers push to protect Chile's cherished night sky from an industrial project

Jazz Pharmaceuticals announced positive Phase 3 results for Ziihera in HER2-positive gastroesophageal cancer. The study showed significant improvements in progression-free survival and overall survival with Ziihera combinations, compared to the control arm. Results will be presented at the 2026 ASCO GI Symposium.

Jazz Pharmaceuticals Announces Positive Phase 3 Results for Ziihera in HER2-Positive Gastroesophageal Cancer

The article discusses the trading setup for AES Corp, highlighting its interaction with the 50-day moving average and a bull flag pattern. The author emphasizes risk management and patience, advising traders to wait for a confirmed breakout above the 50-day moving average before entering. The strategy includes setting a stop-loss below recent consolidation lows and targeting a move to recent highs, while monitoring volume for confirmation.

Talkmarkets

Trading AES Corp: Will It Break The 50-Day Moving Average?

Bunge Positioned for Earnings Growth After Viterra Deal, BofA Says

marketscreener

Bunge Global SA

Bunge Positioned for Earnings Growth After Viterra Deal, BofA Says

BofA Global Research raises the price target on Bungeto $112 from $95, representing a 16.1% upside. The brokerage expects synergies from the Viterra deal and organic investments to support growth, with most synergies materializing by 2027. BofA favors BG's significant exposure to South America. Nine out of 12 brokerages rate the stock as 'buy' and 3 as 'hold', with a median PT of $109. BG was up 24% YTD as of the last close.

BUZZ-BofA raises PT on Bunge

03:28 AM EST, 12/02/2025 (MT Newswires) -- Bruce C Cozadd, Director, on November 26, 2025, sold 77,500 shares in Jazz Pharmaceuticals ( JAZZ ) for $13,780,337. Following the Form 4 filing with the SEC, Cozadd has control over a total of 393,332 ordinary shares of the company, with 393,332 shares held directly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

fidelity

Jazz Pharmaceuticals Insider Sold Shares Worth $13,780,337, According to a Recent SEC Filing

Director Kenneth W. O'Keefe of Jazz Pharmaceuticals Plc filed a Form 144 with the SEC to sell 1,249 shares on December 1, 2025. The sale is planned for December 2, 2025, through E-TRADE Financial. Form 144 is required for selling restricted stock within 90 days of filing.

Dir O'Keefe Files To Sell 1,249 Of Jazz Pharmaceuticals Plc [JAZZ]

Cozadd Bruce C Chairman of the Board of Jazz Pharmaceuticals Plc [JAZZ] filed a Form 4 on December 1, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:DateTransactionSharesPriceValue11/26/25Exercise(1) 77,500$123.36$9,560,40011/26/25Sale77,500$177.81$13,780,337Ending Holdings: 393,332 - Direct(1) Exercised 3.0 months before expiration date.For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Chmn Cozadd Sells 77,500 ($13.8M) Of Jazz Pharmaceuticals Plc [JAZZ]